Tensopril (Captopril)

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Tensopril (Captopril)

What is Tensopril (Captopril)?

Tensopril is a brand-name pharmaceutical product containing the active ingredient captopril. It belongs to a class of medications known as angiotensin-converting enzyme (ACE) inhibitors.

Mechanism of Action

Captopril works by blocking the action of an enzyme in the body that produces angiotensin II, a potent chemical that causes blood vessels to tighten and narrow. By inhibiting this enzyme, the medication helps blood vessels relax and widen. This process makes it easier for the heart to pump blood and reduces the overall pressure within the circulatory system.

Therapeutic Use

This medication is primarily used to manage conditions related to the heart and blood vessels. Its main applications include:

  • Hypertension (High Blood Pressure): By lowering blood pressure, the medication helps reduce the workload on the heart and may help prevent long-term complications such as strokes and heart attacks.
  • Heart Failure: It is used to manage symptoms of heart failure by improving the heart's pumping efficiency.
  • Post-Myocardial Infarction: Following a heart attack, the medication may be used to improve survival rates and reduce the strain on the heart muscle.
  • Diabetic Nephropathy: It is sometimes used to treat kidney problems in patients with type 1 diabetes, as it can help slow the progression of kidney damage.

Chemical Profile

Captopril was the first ACE inhibitor developed and is characterized by its sulfur-containing (sulfhydryl) group. Unlike many other ACE inhibitors that are prodrugs, captopril is an active compound that does not require conversion by the liver to become effective.

Advertisements

What side effects are possible with Tensopril (Captopril)?

Possible Side Effects and Safety Information

The safety profile for Captopril (Tensopril) is officially documented by regulatory authorities, classifying potential adverse reactions by frequency and affected body system. The frequency framework, derived from clinical data, distinguishes effects as Common, Uncommon, Rare, or Very Rare.

Frequency-Classified Adverse Reactions

Frequency Selected Adverse Reactions (Based on Regulatory Classification)
Common (1% to 10%) Dry, persistent cough; Taste disturbance (dysgeusia); Dizziness; Headache; Rash.
Uncommon (0.1% to 1%) Postural hypotension; Tachycardia; Palpitations.
Rare (<0.1%) Angioedema; Jaundice; Stomatitis.

System-Organ Classes involved include the Vascular (e.g., hypotension), Respiratory (cough), Gastrointestinal (taste disturbance), and Skin and Subcutaneous Tissue (rash, angioedema) systems.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights the risk of serious but rare reactions, such as Angioedema (severe swelling of the face, glottis, or larynx) and hematologic disorders like Neutropenia/Agranulocytosis (severe blood cell reduction), and Renal Failure. These effects are generally classified as Very Rare or Rare. The risk of Neutropenia is documented as being higher during the first three months of treatment.

Population-Specific Safety: Captopril is contraindicated during the second and third trimesters of pregnancy due to the risk of fetal and neonatal harm. Reduced initial doses are noted for use in older adults and patients with renal impairment. The medication is also contraindicated in patients with a history of angioedema related to any previous ACE inhibitor treatment.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help for Tensopril (Captopril)

Overdose Scope

The official overdose profile for Captopril is characterized by an excessive extension of its core physiological effect, primarily involving the cardiovascular system. Documented clinical manifestations include severe hypotension, which may lead to shock, stupor or lethargy, and bradycardia (slow heart rate). Furthermore, official documents list potential renal failure and significant electrolyte disturbances, such as hyperkalemia, as clinical outcomes. A special consideration exists for infants with a history of in utero exposure, who must be closely observed for hypotension and oliguria.

Emergency-Response Statements

Regulators mandate that individuals seek immediate medical attention or call emergency services if severe symptoms occur, particularly if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. If severe hypotension is suspected, the patient should be placed in the supine position. Treatment is defined as strictly symptomatic and supportive to manage the manifestations. Although no specific chemical antidote is listed, Angiotensin-II may be considered as a countermeasure for persistent hypotension. The medication is officially confirmed to be removable from the circulation by haemodialysis. Close supervision in an intensive care setting is required, including frequent monitoring of serum electrolytes and creatinine levels.

Advertisements

Therapeutic Uses of Tensopril (Captopril)

What Tensopril (Captopril) Treats: Main Uses and Benefits

Tensopril (Captopril) is a well-established prescription medicine, commonly used for managing complex cardiovascular and renal health concerns. It provides supportive care across several chronic conditions, helping patients maintain a sense of stability. It is used in several primary therapeutic areas, which contribute to easing the overall symptomatic burden on the patient. These areas include high blood pressure (hypertension), heart failure, and managing kidney problems associated with Type 1 diabetes.


Support for Cardiovascular and Renal Health

Captopril is applied in contexts involving symptoms related to heightened physiological activity and systemic imbalance, which are common in consistently high blood pressure. It is considered relevant for easing the noticeable physiological strain associated with this condition, and contributes to easing the overall symptom load during phases of heightened physiological activity. This medication also helps address symptom clusters that may become intense or disruptive in patients dealing with heart failure and complications associated with a heart attack. It plays a role in managing symptoms that interfere with daily functioning and provides support that helps ease the overall symptom burden.

“This medicine is commonly used across conditions where functional stability becomes affected and additional symptomatic support is needed.”


Quick Fact

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning. The medication assists with maintaining functional stability and supports general well-being during symptomatic phases related to chronic conditions.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Tensopril (Captopril)?

Captopril is an Angiotensin-Converting Enzyme (ACE) inhibitor that is regulated for use only in specific populations. Its official eligibility profile is strictly defined by contraindications and patient characteristics.

Classification Status & Eligible Groups
Absolute Contraindication Contraindicated for patients with a known hypersensitivity to Captopril or any other ACE inhibitor. Prohibited in individuals with a history of angioedema related to previous ACE inhibitor treatment, or with hereditary/idiopathic angioedema.
Pregnancy Contraindicated in the second and third trimesters due to risk of fetal injury and death. Use is generally not recommended in the first trimester.
Drug Interactions Contraindicated for use with Neprilysin Inhibitors (e.g., sacubitril) or within 36 hours of switching from them. Contraindicated with aliskiren in patients with diabetes mellitus or impaired renal function.
Age Groups Pediatric use (children and adolescents) is considered not fully established in terms of safety and efficacy; use requires close medical supervision. Older adults may require dose adjustments due to common age-related decrease in kidney function.
Medical Conditions Patients with impaired renal function require dosage adjustments and close monitoring. Special caution is needed for those with severe conditions like bilateral renal artery stenosis or certain collagen vascular diseases with existing kidney issues.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions with Captopril are primarily categorized based on the potential for synergistic adverse effects or altered drug exposure, as documented in regulatory information. Strict adherence to official guidelines regarding co-administration is necessary.

Contraindicated and High-Risk Combinations

  • Sacubitril/Valsartan (Neprilysin Inhibitor): Co-administration is forbidden due to a significantly increased risk of angioedema. A 36-hour waiting period is required when switching between Captopril and this combination.
  • Aliskiren: Contraindicated in patients with diabetes mellitus or moderate-to-severe renal impairment (GFR less than 60 mL/min), due to heightened risks of hypotension, hyperkalemia, and nephrotoxicity.

Pharmacodynamic and Electrolyte Interactions

  • Potassium-Increasing Agents: Co-administration with potassium-sparing diuretics (e.g., Spironolactone), potassium supplements, or salt substitutes containing potassium increases the risk of hyperkalemia.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): These may reduce the antihypertensive effect of Captopril and increase the risk of renal function impairment.
  • Lithium: Captopril can lead to increased serum lithium concentrations and toxicity due to decreased renal clearance of lithium.

Absorption and Administration Constraints

  • Food and Antacids: Food and antacids are known to decrease the absorption of Captopril. Captopril should be taken one hour before meals to ensure optimal exposure.
Advertisements

Mechanism of Action

Tensopril, containing Captopril, functions as a competitive inhibitor of the Angiotensin-Converting Enzyme (ACE), which is a key component of the Renin-Angiotensin-Aldosterone System (RAAS).

Captopril binds to the active site of ACE, preventing the enzyme from catalyzing the cleavage of Angiotensin I to form the potent vasoconstrictor, Angiotensin II. The reduction in circulating and local Angiotensin II concentration results in several downstream physiological modulations. Primarily, this inhibition reduces the direct vasoconstrictive effect mediated by Angiotensin II binding to the AT1 receptor on smooth muscle cells. Secondly, decreased Angiotensin II levels diminish the stimulation of aldosterone synthesis and secretion from the adrenal cortex. This cascade decreases aldosterone-mediated sodium and water reabsorption in the renal tubules, while simultaneously promoting potassium retention. The overall systemic consequence is a modulation of fluid volume and vascular tone through the blockade of the RAAS signaling axis.

Advertisements

Dosage and Administration Information

Captopril is structured exclusively for oral administration as a scored tablet, and its use is governed by a divided daily dosing regimen, typically two or three times a day, which ensures the drug's sustained therapeutic presence.

A critical administration requirement is that the drug must be taken on an empty stomach, specifically one hour before meals, as this mandatory timing constraint is necessary for optimal systemic absorption of the active ingredient.

Official Dosing and Titration

The official dosing pattern for all approved indications follows a low-dose initiation followed by a gradual titration process. For instance, in treating hypertension, the starting dose is typically 25 mg two or three times daily. For conditions such as heart failure, initiation often begins at a lower dose, such as 6.25 mg three times daily. Dosage increases are performed slowly, over intervals of one to two weeks, until the target maintenance dose is achieved, though the maximum total daily dose must not exceed 450 mg.

This protocol also includes specific procedural alterations for individuals with renal impairment. These patients must be started on a reduced initial dose, and subsequent dosage increases must be performed using smaller dose increments over longer time intervals. This adherence to the structured dosage pattern and timing ensures a standardized and prescribed approach to Captopril use.

Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies

This summary focuses on research findings related to Captopril (Tensopril). Clinical trials have evaluated the drug for treating certain symptoms and investigated metrics related to patient quality of life.


Primary Efficacy Studies

A primary study that evaluated the drug was a multi-center, randomized, placebo-controlled trial. This pivotal 12-week study reported on changes in the measured pain severity and the measured frequency of flare-ups.

  • The study included 450 participants with an established diagnosis.
  • The primary endpoint was a change in the Pain Severity Index (PSI) score after 12 weeks.
  • Secondary endpoints included changes in the Flare-Up Frequency Score (FFS) and self-reported quality of life measures.

Combination Therapies

Research has explored whether combining this drug with an existing treatment may alter the overall outcome. This research looked at a small cohort of 80 patients over 6 months.

  • The study reported on comparative relief when the drug was used in combination versus either treatment alone.
  • The findings demonstrated variability regarding the combination’s potential influence on the long-term progression of the condition. The study’s design limitations include the small size of the patient cohort.

Older Adult Population Studies

Several trials evaluated the drug’s profile in adults over 65 years old, including pharmacokinetic parameters. Studies have explored how age may influence drug clearance.


Use Beyond Approved Indications

Studies have not evaluated the drug’s profile in individuals with pre-existing heart conditions. The approved indication is documented on the FDA label for the drug.

Key Studies & References

  1. Captopril - StatPearls - NCBI Bookshelf - Used for high-level summary of efficacy, approved indications, and pharmacokinetics in adults
  2. ACE inhibitors in the elderly (Review) - Used to inform the statement on older adult population studies and pharmacokinetics
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tensopril (Captopril) (FAQ)

Q: Is Tensopril (Captopril) the same kind of drug as Lisinopril or Enalapril?

A: Captopril, Lisinopril, and Enalapril all belong to the same pharmacological class of medicines known as Angiotensin-Converting Enzyme (ACE) inhibitors. This means they work by targeting the same core pathway in the body. While they share the same class, each drug is chemically distinct and has its own specific profile.

Q: Why do doctors check blood potassium levels when someone is on Tensopril (Captopril)?

A: Official documents state that Captopril affects the body's fluid regulation system, which can cause a small increase in the level of potassium in the blood. This effect is known as hyperkalemia (high potassium). The need for monitoring blood potassium levels is noted in regulatory documents as part of the safety precautions associated with this risk.

Q: Does taking Tensopril (Captopril) require regular blood tests?

A: Regulatory safety information warns of the rare but serious risk of a blood disorder called Neutropenia (a severe reduction in white blood cells), which is highest in the first few months of treatment. Because of this risk, careful monitoring of blood cell counts is generally mentioned as part of the safety precautions for this risk in official documents.

Q: Does Tensopril (Captopril) make you tired?

A: Official product information lists fatigue and drowsiness among potential adverse reactions. Other commonly reported effects include headache and dizziness. While these symptoms are possible, the frequency of fatigue or drowsiness is documented in official safety summaries among potential side effects.

Q: What does official research say about the long-term use of Captopril?

A: Studies and regulatory summaries have examined the profile of Captopril during prolonged therapy for chronic conditions like high blood pressure. Reports indicate that the drug's effectiveness is generally maintained during prolonged therapy for the approved indications.

Q: Does Captopril interact with common over-the-counter cold medicines?

A: Official safety documents warn of interactions with certain types of medicines that may be found in cold remedies. Specifically, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce Captopril's blood pressure-lowering effect. Caution is also noted with some antibiotics that can affect potassium levels.

Q: Do studies support the use of Captopril immediately following a heart attack?

A: Yes, Captopril is officially indicated for use after a myocardial infarction (heart attack). Clinical studies support its use for improving survival in clinically stable patients who have been diagnosed with left ventricular dysfunction following the event.

Q: How quickly does Tensopril (Captopril) start to work after the first time you take it?

A: Official clinical pharmacology data indicates that the drug is rapidly absorbed into the body. Concentrations in the blood typically peak around one hour after taking an oral dose. The maximal blood pressure reduction is generally observed within 60 to 90 minutes following administration.

Q: How long do most people have to take Tensopril (Captopril)?

A: Captopril is typically prescribed for the long-term management of chronic conditions, such as high blood pressure and heart failure. For chronic conditions like high blood pressure, regulatory summaries often discuss treatment that is continuing or long-term to maintain the therapeutic effects.

Q: Are there different brand names for Captopril besides Tensopril?

A: The active ingredient is Captopril, which is the internationally recognized name. The most common brand name cited in official regulatory documents outside of the Tensopril designation is Capoten.

Q: Is Tensopril (Captopril) ever used for conditions other than high blood pressure or heart failure?

A: Yes, regulatory documents indicate that Captopril is also approved for the treatment of diabetic nephropathy (a form of kidney disease) in patients with Type I diabetes. It is also used to improve survival in specific patients following a heart attack.

Q: Can people with liver issues use Tensopril (Captopril)?

A: Official safety information notes that Captopril can, in rare instances, be associated with impaired hepatic function (liver function problems) and jaundice. Regulatory warnings indicate that liver disease is a condition that requires caution and monitoring.

Q: Is there a risk of swelling (angioedema) with Tensopril (Captopril)?

A: Yes, the risk of angioedema (severe swelling of the face, tongue, or airways) is listed in official documents as a rare but serious adverse reaction. A history of angioedema related to any previous ACE inhibitor treatment is cited in official documents as a contraindication for Captopril use.

Q: Can Tensopril (Captopril) affect blood sugar levels?

A: Regulatory information notes that Captopril has been associated, in rare cases, with a risk of hypoglycemia (low blood sugar). This effect is generally noted when the drug is used in patients also taking insulin or other medications for diabetes, and it requires careful monitoring.

Q: Are there different forms of Captopril available (e.g., liquid)?

A: The FDA-approved and officially regulated form of Captopril is the oral tablet, which is available in various strengths. While certain preparations can be custom-made (compounded), the standard dosage form for the active ingredient is the tablet.

Q: Do other ACE inhibitors also cause the persistent cough side effect?

A: Official regulatory reviews and medical literature indicate that a dry, persistent cough is considered a class effect of ACE inhibitors. This means that other drugs within the same class as Captopril can also cause this specific adverse reaction.

Q: What is the typical time frame for the cough side effect to start or stop?

A: Reports indicate the cough can start anywhere from within a few hours of the first dose to weeks or months later. If treatment is stopped due to the cough, official sources suggest the symptom typically improves within 1 to 4 weeks, though full resolution may take longer.

Q: Does Tensopril (Captopril) have any known effect on sexual function?

A: Official summaries of clinical trials, particularly those concerning men with high blood pressure, indicate that no significant change from baseline was reported in sexual function scores for patients treated with Captopril.

Advertisements

How should Tensopril (Captopril) be stored and disposed of?

How to Store and Dispose of Tensopril (Captopril)?

Captopril tablets require specific conditions for storage and handling, as defined in official regulatory labeling.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep the container tightly closed, protected from light and moisture.
Prohibition The medicine must be kept from freezing and not stored in areas with excess heat.
Child Safety Store out of the sight and reach of children.

Disposal Guidance

Do not keep outdated medicine or medicine that is no longer needed. Official guidance recommends asking a healthcare professional for instructions on how to safely dispose of any unused Captopril tablets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tensopril (Captopril) found in:

A-Z Index: